Alzheimer's disease is a chronic neurodegenerative illness that is one of the most persistent
medical concerns with significant social and economic consequences. Current treatments …

Alzheimer's disease (AD) is one among the common type of dementia in elder people above
the age group of 65 years. This was once considered a rare disorder but in recently was …

Alzheimer's disease (AD) is a “progressive, neurodegenerative disease that occurs when
nerve cells in the brain die.” There are only 4 drugs approved by the United States Food and …

Background & Objective: Diabetes is one of the most common metabolic disorders. Alpha-
amylase plays an important role in the development of diabetes by breaking down …

Background: Alzheimer's disease is a memory loss problem associated mostly with elderly
people, the cause of this disease is generally accumulation of beta-amyloid plaques around …

Amyloidogenic pathway in Alzheimer's disease (AD) involves breakdown of APP by β‐
secretase followed by γ‐secretase and results in formation of amyloid beta plaque. β …

Introduction: Apolipoprotein E4 (ApoE) is a major genetic factor for developing Alzheimer's
disease (AD). It plays a vital role in brain to maintain a constant supply of neuronal lipids for …

Aims: Alzheimer's disease is a disorder associated to dementia that widely affects to
population. In the molecular study, key enzymes have been associated with the regulation of …

Alzheimer (AD) is a chronical neurodegenerative disease which is the 6th leading cause of
death worldwide. About 36 million cases in the world and may increase to 115 million in …